By Michael Bartlett on June 09th, 2026 in Ethylene Oxide
A breast cancer diagnosis is difficult enough on its own. When it arrives without a family history, without a positive BRCA result, and without any obvious explanation, the questions that follow can be just as hard to carry.
Research into environmental carcinogens is offering some of those answers, and ethylene oxide is one chemical that has drawn serious scientific attention. If you developed breast cancer after living near an ethylene oxide facility, ELG Law can review your situation and let you know whether you may have a claim.
One of the most commonly misunderstood facts about breast cancer is how rarely genetics accounts for a diagnosis. According to the National Cancer Institute, only 5 to 10 percent of breast cancers are linked to inherited genetic mutations. BRCA1 and BRCA2 are the most well-known hereditary breast cancer genes, but most people diagnosed with the disease test negative for both. The American Cancer Society confirms that most individuals diagnosed with breast cancer do not have a first-degree relative with the disease.
That leaves roughly 90 to 95 percent of breast cancer cases that cannot be explained by hereditary mutations alone. For many patients, negative genetic testing does not close the question. It opens it.
When genetics do not explain a diagnosis, researchers look elsewhere. The National Institute of Environmental Health Sciences funds ongoing research specifically examining how environmental factors may contribute to breast cancer risk. Areas under active investigation include air pollution, industrial emissions, endocrine-disrupting chemicals, and occupational and residential exposures to known carcinogens.
Ethylene oxide has become one of the more closely studied chemicals in this context. The EPA has concluded that ethylene oxide is carcinogenic to humans and that long-term inhalation exposure increases cancer risk. Studies have begun examining residential exposure near industrial EtO facilities as a potential contributor to breast cancer risk.
A study in Environmental Health Perspectives of people living near industrial sources of ethylene oxide found that higher estimated levels of exposure were associated with a higher risk for DCIS, a non-invasive form of breast cancer that is considered an early stage of the disease.
What makes this study particularly relevant is that it focused on environmental exposure, not workplace exposure. The elevated risk was found among those who simply lived near facilities emitting ethylene oxide, not among those who worked with the chemical directly. For anyone who spent years or decades living near an EtO-emitting facility, that distinction matters.
The EPA's cancer risk modeling for ethylene oxide is built around chronic, long-term, cumulative exposure. That framework means a diagnosis today may reflect exposure that began years or even decades earlier. Someone who grew up near an EtO facility, lived in the same area through adolescence, or resided near an emitting site for 10, 20, or 30 years before a diagnosis may have accumulated significant exposure long before any symptoms appeared.
This is a pattern seen across environmental cancer research. The gap between exposure and diagnosis, known as the latency period, means that the cause of a cancer and the moment it is detected can be separated by an entire chapter of someone's life.
If you have been diagnosed with breast cancer and your experience includes any of the following, environmental exposure may be worth exploring:
These are not disqualifying circumstances. For many patients, they are the starting point for understanding what may have contributed to their diagnosis.
ELG Law has spent over three decades representing individuals who developed cancer following toxic chemical exposure. If you have been diagnosed with breast cancer and lived near an ethylene oxide facility, your residential history and medical records are the foundation of a potential claim. Contact ELG Law for a free case evaluation and find out whether your diagnosis and exposure history support a case.